Company News

  • Pleased to announce that the United Kingdom, United States, Europe, Australia, China, Japan, Hong Kong, Israel and Russian Patent Office has granted two patent applications to Haoma Medica Limited, patents GB2476643 and patents GB2476644
  • Haoma Medica has patents pending across Brazil, Canada, India and South Korea
  • Filings will cover 95% of the people effected by Osteoporosis and Osteopenia
  • Proof-of-Principle trials have been completed
  • Pre-Clinical Trials began late 2016
  • Phase I Trials to follow in 2018
  • Phase IIa Trials to follow in 2019

Osteoporosis News

  • Finding New Health Benefits for Vitamin K - Vitamin K, once thought important primarily for blood clotting, may have a much wider array of health benefits. more...

  • Prevention of Costly Hip Fractures Should be a Priority in the UK - Hip fractures account for an estimated £1.1 billion in hospital costs annually. more...

  • Osteoporosis-Related Fractures in China Expected to Double by 2035 - Fractures in China's elderly population represent a growing economic burden to the Chinese healthcare system. more...

Patient Community

  • Osteoporosis Patient Community more...
  • Joining The Patient Community more...
  • Trial Dates And Locations more...

Osteoporosis Q&A